These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10747762)

  • 1. Estimating the long-term cost savings from the treatment of Alzheimer's disease: a modelling approach.
    Neumann PJ
    Pharmacoeconomics; 2000 Jan; 17(1):109. PubMed ID: 10747762
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer's disease care: costs and potential savings.
    Leon J; Cheng CK; Neumann PJ
    Health Aff (Millwood); 1998; 17(6):206-16. PubMed ID: 9916370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential cost savings for selected non-pharmacological treatment strategies for patients with Alzheimer's disease in Finland.
    Rosenvall A; Sääksvuori L; Finne-Soveri H; Linnosmaa I; Malmivaara A
    J Rehabil Med; 2020 Sep; 52(9):jrm00106. PubMed ID: 32778901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain in people with Alzheimer's disease.
    Naierman N
    Health Aff (Millwood); 2014 Jul; 33(7):1303. PubMed ID: 25006162
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost analysis of early psychosocial intervention in Alzheimer's disease.
    Søgaard R; Sørensen J; Waldorff FB; Eckermann A; Buss DV; Waldemar G
    Dement Geriatr Cogn Disord; 2014; 37(3-4):141-53. PubMed ID: 24157706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the potential cost savings from the New York University Caregiver Intervention in Minnesota.
    Long KH; Moriarty JP; Mittelman MS; Foldes SS
    Health Aff (Millwood); 2014 Apr; 33(4):596-604. PubMed ID: 24711320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating long-term cost savings from treatment of Alzheimer's disease. A modelling approach.
    Fenn P; Gray A
    Pharmacoeconomics; 1999 Aug; 16(2):165-74. PubMed ID: 10539397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease: research advances and medical reality.
    Seiguer E
    Issue Brief (Commonw Fund); 2005 Jul; (828):1-10. PubMed ID: 16189900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caring for patients with Alzheimer's disease in Italy.
    Mantovani LG; Belisari A
    CMAJ; 1999 Nov; 161(11):1390, 1392. PubMed ID: 10906892
    [No Abstract]   [Full Text] [Related]  

  • 10. North Dakota assistance program for dementia caregivers lowered utilization, produced savings, and increased empowerment.
    Klug MG; Halaas GW; Peterson ML
    Health Aff (Millwood); 2014 Apr; 33(4):605-12. PubMed ID: 24711321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The health economics of Alzheimer's disease.
    Nurs Stand; 1998 Apr 29-May 5; 12(32):32-3. PubMed ID: 9668823
    [No Abstract]   [Full Text] [Related]  

  • 12. Alzheimer's disease and the family caregiver: the cost and who pays?
    Taylor DH
    N C Med J; 2005; 66(1):16-23. PubMed ID: 15786673
    [No Abstract]   [Full Text] [Related]  

  • 13. Modelling the clinical and economic implications of galantamine in the treatment of mild-to-moderate Alzheimer's disease in Germany.
    Guo S; Hernandez L; Wasiak R; Gaudig M
    J Med Econ; 2010; 13(4):641-54. PubMed ID: 20958114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study notes huge costs associated with Alzheimer's disease.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Feb; 13(4):7-9. PubMed ID: 12434776
    [No Abstract]   [Full Text] [Related]  

  • 15. The costs and social burdens of Alzheimer disease: what can and should be done?
    Hay JW; Sano M; Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1997 Dec; 11(4):181-3. PubMed ID: 9437434
    [No Abstract]   [Full Text] [Related]  

  • 16. National plan to address Alzheimer's disease offers hope for new home care and hospice provisions.
    Sokol EW
    Caring; 2013 Jan; 32(1):24-7. PubMed ID: 23634509
    [No Abstract]   [Full Text] [Related]  

  • 17. Relation between severity of Alzheimer's disease and costs of caring.
    Hux MJ; O'Brien BJ; Iskedjian M; Goeree R; Gagnon M; Gauthier S
    CMAJ; 1998 Sep; 159(5):457-65. PubMed ID: 9757169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to deal with missing longitudinal data in cost of illness analysis in Alzheimer's disease-suggestions from the GERAS observational study.
    Belger M; Haro JM; Reed C; Happich M; Kahle-Wrobleski K; Argimon JM; Bruno G; Dodel R; Jones RW; Vellas B; Wimo A
    BMC Med Res Methodol; 2016 Jul; 16():83. PubMed ID: 27430559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Annual economic cost of informal care in Alzheimer's disease].
    Turró-Garriga O; López-Pousa S; Vilalta-Franch J; Turon-Estrada A; Pericot-Nierga I; Lozano-Gallego M; Hernández-Ferràndiz M; Soler-Cors O; Planas-Pujol X; Monserrat-Vila S; Garre-Olmo J
    Rev Neurol; 2010 Aug; 51(4):201-7. PubMed ID: 20648463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic impact of moderate stage Alzheimer's disease in Italy: evidence from the UP-TECH randomized trial.
    Chiatti C; Furneri G; Rimland JM; Demma F; Bonfranceschi F; Cassetta L; Masera F; Cherubini A; Corsonello A; Lattanzio F;
    Int Psychogeriatr; 2015 Sep; 27(9):1563-72. PubMed ID: 25874654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.